Mitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress

Mario Arciello1, Manuele Gori2, Clara Balsano3

  • 1Department of Internal Medicine and Medical Specialties, "Sapienza" University of Rome, Via del Policlinico 155, 00161 Rome, Italy ; Francesco Balsano Foundation, Via G.B. Martini 6, 00198 Rome, Italy.

Insights

Hepatitis C virus (HCV) infection causes oxidative stress, primarily through mitochondrial dysfunction and metal imbalance. Targeting these factors may improve HCV treatment and reduce liver damage.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatitis C virus (HCV) infection leads to significant pathology via molecular and metabolic pathways.
  • Oxidative stress is a key factor in HCV pathology, but current antioxidant therapies have limited efficacy.
  • HCV infection induces oxidative stress through various mechanisms, including enzyme activation, weakened antioxidant defenses, organelle damage, and metal imbalance.

Purpose of the Study:

  • To review the role of mitochondria and metals in HCV-related oxidative stress.
  • To highlight the overlooked contribution of metal deregulation to oxidative stress exacerbation in HCV.
  • To emphasize the importance of considering mitochondrial and metal dysregulation in managing HCV liver damage and antiviral treatment.

Main Methods:

  • Literature review focusing on molecular and metabolic pathways involved in HCV pathology.
  • Analysis of the interplay between HCV, oxidative stress, mitochondria, and metal homeostasis.
  • Synthesis of current understanding regarding mitochondrial dysfunction and metal imbalance in HCV infection.

Main Results:

  • Mitochondrial failure is central to HCV-related oxidative stress onset.
  • Mitochondria are direct viral targets and key producers/targets of free radicals.
  • Mitochondrial dysfunction significantly contributes to metal imbalance, exacerbating oxidative stress and potentially influencing the HCV life cycle.

Conclusions:

  • Mitochondrial dysfunction and metal imbalance are critical, often overlooked, factors in HCV pathogenesis.
  • Understanding the role of mitochondria and metals in HCV-related oxidative stress is crucial for effective patient management.
  • Targeting mitochondrial and metal deregulation may offer new therapeutic strategies for HCV infection and associated liver damage.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
13.8K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
151